Recombinant multi-species PDGF-D/PDGFD protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PDGF-D/PDGFD protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the platelet-derived growth factor family. The four members of this family are mitogenic factors for cells of mesenchymal origin and are characterized by a core motif of eight cysteines, seven of which are found in this factor. This gene product only forms homodimers and, therefore, does not dimerize with the other three family members. It differs from alpha and beta members of this family in having an unusual N-terminal domain, the CUB domain. Two splice variants have been identified for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: PDGF-D, PDGFD,Platelet-derived growth factor D,PDGF-D,Iris-expressed growth factor, Spinal cord-derived growth factor B (SCDGF-B),IEGF,SCDGFB,MSTP036,SCDGF-B

Target products collectionGo to PDGF-D/PDGFD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T90464-Ab-1/ GM-Tg-hg-T90464-Ab-2 Human PDGF-D/PDGFD protein Human
GM-Tg-rg-T90464-Ab-1/ GM-Tg-rg-T90464-Ab-2 Rat PDGF-D/PDGFD protein Rat
GM-Tg-mg-T90464-Ab-1/ GM-Tg-mg-T90464-Ab-2 Mouse PDGF-D/PDGFD protein Mouse
GM-Tg-cynog-T90464-Ab-1/ GM-Tg-cynog-T90464-Ab-2 Cynomolgus/Rhesus macaque PDGF-D/PDGFD monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-T90464-Ab-1/ GM-Tg-felg-T90464-Ab-2 Feline PDGF-D/PDGFD protein Feline
GM-Tg-cang-T90464-Ab-1/ GM-Tg-cang-T90464-Ab-2 Canine PDGF-D/PDGFD protein Canine
GM-Tg-bovg-T90464-Ab-1/ GM-Tg-bovg-T90464-Ab-2 Bovine PDGF-D/PDGFD protein Bovine
GM-Tg-equg-T90464-Ab-1/ GM-Tg-equg-T90464-Ab-2 Equine PDGF-D/PDGFD protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T90464-Ab-1/ GM-Tg-hg-T90464-Ab-2; GM-Tg-rg-T90464-Ab-1/ GM-Tg-rg-T90464-Ab-2;
GM-Tg-mg-T90464-Ab-1/ GM-Tg-mg-T90464-Ab-2; GM-Tg-cynog-T90464-Ab-1/ GM-Tg-cynog-T90464-Ab-2;
GM-Tg-felg-T90464-Ab-1/ GM-Tg-felg-T90464-Ab-2; GM-Tg-cang-T90464-Ab-1/ GM-Tg-cang-T90464-Ab-2;
GM-Tg-bovg-T90464-Ab-1/ GM-Tg-bovg-T90464-Ab-2; GM-Tg-equg-T90464-Ab-1/ GM-Tg-equg-T90464-Ab-2
Products Name PDGF-D/PDGFD protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PDGF-D/PDGFD
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PDGF-D/PDGFD protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.